Alexandro Andrade1,2, Ricardo de Azevedo Klumb Steffens3,4,5, Sofia Mendes Sieczkowska3,4, Leonardo Alexandre Peyré Tartaruga6,7, Guilherme Torres Vilarino3,4. 1. Health and Sports Science Center, CEFID / Santa Catarina State University - UDESC, Florianópolis, SC, Brazil. alexandro.andrade.phd@gmail.com. 2. Laboratory of Sports and Exercise Psychology - LAPE, Florianópolis, SC, Brazil. alexandro.andrade.phd@gmail.com. 3. Health and Sports Science Center, CEFID / Santa Catarina State University - UDESC, Florianópolis, SC, Brazil. 4. Laboratory of Sports and Exercise Psychology - LAPE, Florianópolis, SC, Brazil. 5. Regional University of Blumenau - FURB, Blumenau, SC, Brazil. 6. Human Movement Sciences and Pneumological Sciences, UFRGS- Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil. 7. Research Laboratory of Exercise - LAPEX, Porto Alegre, RS, Brazil.
Abstract
BACKGROUND: Fibromyalgia (FM) is characterized by chronic and generalized musculoskeletal pain. There is currently no cure for FM, but palliative treatments are available. One type of treatment is strength training (ST). However, there is a need for more information on optimal training protocols, intensity, and volume needed to improve symptoms. The aim of this study was to analyze the effects of ST in the treatment of FM through a systematic review of experimental research. METHODS: Medical Subject Headings search terms and electronic databases including Scientific Electronic Library Online, PubMed, Science Direct, Web of Science, and Physiotherapy Evidence Database were used to identify studies. RESULTS: The inclusion criteria were met by 22 eligible studies. Most of the studies were conducted in the United States (36%), Finland (23%), Brazil (18%), and Sweden (18%). The studies showed that ST reduces the number of tender points, fatigue, depression, and anxiety, and improves sleep quality and quality of life in patients with FM. The intervention period ranged from 3 to 21 weeks, with sessions performed 2 times a week in 81.81% of the studies, at initial intensities of 40% of 1-repetition maximum. The repetitions ranged from 4 to 20, with no specific protocol defined for ST in FM. CONCLUSION: The main results included reduction in pain, fatigue, number of tender points, depression, and anxiety, with increased functional capacity and quality of life. Current evidence demonstrates that ST is beneficial and can be used to treat FM. TRIAL REGISTRATION: CRD42016048480.
BACKGROUND:Fibromyalgia (FM) is characterized by chronic and generalized musculoskeletal pain. There is currently no cure for FM, but palliative treatments are available. One type of treatment is strength training (ST). However, there is a need for more information on optimal training protocols, intensity, and volume needed to improve symptoms. The aim of this study was to analyze the effects of ST in the treatment of FM through a systematic review of experimental research. METHODS: Medical Subject Headings search terms and electronic databases including Scientific Electronic Library Online, PubMed, Science Direct, Web of Science, and Physiotherapy Evidence Database were used to identify studies. RESULTS: The inclusion criteria were met by 22 eligible studies. Most of the studies were conducted in the United States (36%), Finland (23%), Brazil (18%), and Sweden (18%). The studies showed that ST reduces the number of tender points, fatigue, depression, and anxiety, and improves sleep quality and quality of life in patients with FM. The intervention period ranged from 3 to 21 weeks, with sessions performed 2 times a week in 81.81% of the studies, at initial intensities of 40% of 1-repetition maximum. The repetitions ranged from 4 to 20, with no specific protocol defined for ST in FM. CONCLUSION: The main results included reduction in pain, fatigue, number of tender points, depression, and anxiety, with increased functional capacity and quality of life. Current evidence demonstrates that ST is beneficial and can be used to treat FM. TRIAL REGISTRATION: CRD42016048480.
Authors: Sofia Mendes Sieczkowska; Guilherme Torres Vilarino; Loiane Cristina de Souza; Alexandro Andrade Journal: Ir J Med Sci Date: 2019-06-04 Impact factor: 1.568
Authors: Maria Luiza L Albuquerque; Diogo Monteiro; Daniel A Marinho; Guilherme T Vilarino; Alexandro Andrade; Henrique P Neiva Journal: Rheumatol Int Date: 2022-05-23 Impact factor: 3.580
Authors: Ruth Izquierdo-Alventosa; Marta Inglés; Sara Cortés-Amador; Lucia Gimeno-Mallench; Javier Chirivella-Garrido; Juri Kropotov; Pilar Serra-Añó Journal: Int J Environ Res Public Health Date: 2020-05-21 Impact factor: 3.390
Authors: María Del-Moral-García; Esteban Obrero-Gaitán; Daniel Rodríguez-Almagro; Manuel Rodríguez-Huguet; María Catalina Osuna-Pérez; Rafael Lomas-Vega Journal: J Clin Med Date: 2020-11-22 Impact factor: 4.241
Authors: Alejandra Cardenas-Rojas; Luis Castelo-Branco; Kevin Pacheco-Barrios; Emad Salman Shaikh; Elif Uygur-Kucukseymen; Stefano Giannoni-Luza; Luna Vasconcelos Felippe; Paola Gonzalez-Mego; Maria Alejandra Luna-Cuadros; Anna Carolyna Lepesteur Gianlorenco; Paulo E P Teixeira; Wolnei Caumo; Felipe Fregni Journal: Contemp Clin Trials Commun Date: 2021-11-17
Authors: Carmen M Galvez-Sánchez; Gustavo A Reyes Del Paso; Stefan Duschek; Casandra I Montoro Journal: J Clin Med Date: 2022-02-05 Impact factor: 4.241
Authors: Marcelo Silva de Carvalho; Leonardo Cesar Carvalho; Ricardo da Silva Alves; Flavia da Silva Menezes; Elenara da Costa Gomes; Andressa Frazin; Denise Hollanda Iunes Journal: Games Health J Date: 2021-06